表紙:ガンマナイフ市場:疾患適応別、解剖学別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1320172

ガンマナイフ市場:疾患適応別、解剖学別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Gamma Knife Market with COVID-19 Impact Analysis, By Disease Indications, By Anatomy, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 312 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
ガンマナイフ市場:疾患適応別、解剖学別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 312 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ガンマナイフ市場規模は2022年に4億8,090万米ドル、2023年から2030年にかけてCAGR 5.3%で拡大

ガンマナイフ市場-市場力学:

非侵襲性&最小限の副作用、認知度&受容性、技術進歩が市場成長を後押し

ガンマナイフは開腹手術を必要とせず、非侵襲的です。また、集束した放射線ビームを使用し、周囲の健康な組織を温存しながら特定の脳領域をターゲットとして治療します。従来の手術法よりも副作用や合併症のリスクが軽減されるため、患者にとってユニークな選択肢となります。さらに、ガンマナイフ手術の利点は、ヘルスケアと患者の専門家の間で認識が高まっていることに起因しています。ガンマナイフ手術の安全性と有効性を裏付ける臨床的証拠が増えるにつれ、この技術の受容と使用は世界的に増加しています。しかし、製品の製造コストが高く、適切なインフラが整っていないことが市場成長の妨げになると予想されます。さらに、ガンマナイフ技術では継続的な進歩が市場成長の機会をもたらしています。これに伴い、メーカーは効率、精度、患者の転帰を改善するために、治療計画ソフトウェア、画像処理能力の向上、放射線照射システムに注力することができます。また、ガンマナイフ技術の応用範囲は、より汎用性が高くコンパクトなシステムの開発によって拡大する可能性があります。このような要因がガンマナイフ市場の需要を促進すると予測されています。

ガンマナイフ市場-主要洞察:

  • 当社のリサーチアナリストが共有した分析によると、世界のガンマナイフ市場は予測期間(2023-2030年)に約5.3%のCAGRで毎年成長すると予測されています。
  • ガンマナイフ産業は、ヘルスケアおよび患者専門家の意識の高まりにより、大きな成長率で成長すると予測されています。
  • 市場セグメンテーションによると、2022年の市場シェアはがんが最大と予測されます。
  • 解剖学的セグメンテーションに基づくと、頭部が2022年の主要タイプでした。
  • 地域別では、北米が2022年に収益を生み出す主要市場となっています。

ガンマナイフ市場-セグメンテーション分析:

世界のガンマナイフ市場は、適応疾患、解剖学的構造、エンドユーザー、地域に基づいてセグメント化されています。

適応疾患に基づいて、がん、眼疾患、脳転移、血管障害、機能障害、運動障害、三叉神経痛、動静脈奇形(AVM)、その他の8つのカテゴリーに分類されます。がん分野は、新たながん患者とがんによる死亡者数の増加により、予測期間中、市場を独占すると予想されます。さらに、この場合、忘れてはならないのは、市場の特定の部分が脳腫瘍で占められていることです。さらに、患者のがんがステージ4を超えると、患者の脳に影響を及ぼしている可能性がかなり高くなります。従って、これらの要素は、セグメントの成長を増加させる要因となっています。

市場は解剖学的構造に基づいて、頸部、頭部、その他の2つのカテゴリーに分類されます。頭部セグメントは、市場において優位性を維持する可能性が高いです。頭部の深部腫瘍を効果的かつ非侵襲的に治療できることが、同分野の需要を後押ししています。さらに、神経外科手術は患者の安全に大きなリスクをもたらすため、頭部の深部腫瘍やがんはガンマナイフ治療が主流となっています。

市場はエンドユーザーによって、外来サービスセンター、病院、診療所の3つに分類されます。市場セグメンテーションでは、病院部門が最大の売上シェアを占めると見られています。ヘルスケア分野では、技術進歩の高まりが同分野の成長を押し上げると予想されています。さらに、コンピュータ誘導治療であるガンマナイフプロセスは、外科医が最高レベルの精度で手技を行うことを可能にします。これは、画像処理ソフトウェアの利用を促進する一方で、市場シェアの急上昇に寄与しています。

ガンマナイフ市場-地理的洞察:

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

ガンマナイフ市場-競合情勢:

ガンマナイフ市場は、神経疾患の罹患率の増加により着実に拡大しています。さらに、世界のガンマナイフ市場は、研究開発活動の拡大、コラボレーション、新製品の発売によって牽引されています。市場の急成長を後押ししている主な要素の1つは、技術、可用性、製品コスト、性能など、主要市場プレイヤーの戦略的取り組みです。さらに、競争上の優位性を獲得するため、主要プレーヤーは製品のラインナップを拡大しています。例えば、Leksell GammaPlanは、Leksell Gamma Knifeと完全に互換性があり、特に頭蓋内放射線手術の要件を満たすように設計された高度な治療計画と管理ソフトウェアです。さらに、効率的で安全な治療ワークフローを確保しながら、システムに実装された高度な技術を完全に活用するための特定のツールも提供しています。

最近の動向

例えば、2022年10月、バリアンとシンシナティ小児/大学は、陽子線フラッシュの初のヒトでの経験であり、超高線量率フラッシュ治療の初の臨床試験であるFAST-01(FeAsibility Study of Flash Radiotherapy for the Treatment of Symptomatic Bone Metastases)の臨床試験結果を発表しました。

研究の主な特徴

  • この調査レポートは、ガンマナイフ市場の市場規模、年間平均成長率(CAGR %)、2022年を基準年とした推定・予測(2023-2030年)を提供しています。
  • この調査レポートは、ガンマナイフ市場に関する最新動向の洞察を顧客に提供します。
  • この調査レポートは、さまざまなセグメント/国にわたる潜在的な成長機会を解明し、ガンマナイフ市場の魅力的な投資提案マトリクスを説明しています。
  • 全体的なレポートでは、新規投資機会、既存企業が直面する課題、ガンマナイフ市場で持続するための成長要因を特定しています。
  • COVID-19がガンマナイフ市場規模、予測、CAGR、市場力学に与える影響については、調査範囲で詳細に論じています。COVID後のガンマナイフ市場に関する詳細な洞察もカバーします。
  • 本レポートの利用者にガンマナイフ市場の包括的な見解を提供するために、ガンマナイフ市場の競合情勢と主要イノベーター分析も含めています。
  • 本調査では、市場規模、成長率、魅力度に基づき、すべての業界セグメントをベンチマークとした成長展望マッピング分析を網羅しています。
  • 本レポートは、ガンマナイフ市場で事業を展開する企業の財務情報や戦略的イニシアチブを理解するのに役立つ主要な市場参入企業を特集した詳細な企業プロファイルを提供しています。
  • さらに、世界レベルだけでなく地域レベルで市場に関わる主要参入企業の重要な買収&合併、提携&ジョイントベンチャー、新発売、研究開発、地域展開についても明らかにしています。
  • ガンマナイフの世界市場レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界の様々な利害関係者を対象としています。

目次

第1章 ガンマナイフ市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ガンマナイフの主要な市場動向

  • ガンマナイフ市場促進要因
  • ガンマナイフ市場抑制要因
  • ガンマナイフ市場の機会
  • ガンマナイフ市場の今後の動向

第4章 ガンマナイフ産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ガンマナイフ市場:COVID-19の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 ガンマナイフ市場情勢

  • ガンマナイフ市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 確立された企業の分析
    • 新興企業の分析

第7章 ガンマナイフ市場- 疾患適応別

  • 概要
    • 疾患適応別のセグメントシェア分析
    • がん
    • 眼疾患
    • 脳転移
    • 血管障害
    • 機能障害
    • 運動障害
    • 三叉神経痛
    • 動静脈奇形(AVM)
    • その他

第8章 ガンマナイフ市場- 解剖学別

  • 概要
    • 解剖学別セグメントシェア分析
    • その他

第9章 ガンマナイフ市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 外来サービスセンター
    • 病院
    • クリニック

第10章 ガンマナイフ市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米のガンマナイフ主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州のガンマナイフ主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋地域のガンマナイフの主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカのガンマナイフ主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカのガンマナイフの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- ガンマナイフ業界

  • 競合ダッシュボード
  • 企業プロファイル
    • American Shared Hospital Services
    • Hitachi, Ltd.
    • Brainlab
    • GENERAL ELECTRIC COMPANY
    • Elekta AB
    • BondWellOrtho
    • Ono Sokki India Private Limited.
    • Blount Memorial Hospital
    • Panacea Medical Technologies Pvt. Ltd.
    • American Radiosurgery Inc.
    • UT Health East Texas.
    • MASEP
    • UT Health East Texas.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Gamma Knife Market: Disease Indications Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Indications
  • TABLE Global Gamma Knife Market, by Disease Indications2018-2030 (USD Million)
  • TABLE Gamma Knife Market: AnatomySnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Anatomy
  • TABLE Global Gamma Knife Market, by Anatomy2018-2030 (USD Million)
  • TABLE Gamma Knife Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Gamma Knife Market, by End User 2018-2030 (USD Million)
  • TABLE Gamma Knife Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Gamma Knife Market, by Region 2018-2030 (USD Million)
  • TABLE North America Gamma Knife Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Gamma Knife Market, by Disease Indications, 2018-2030 (USD Million)
  • TABLE North America Gamma Knife Market, by Anatomy, 2018-2030 (USD Million)
  • TABLE North America Gamma Knife Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Gamma Knife Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Gamma Knife Market, by Disease Indications, 2018-2030 (USD Million)
  • TABLE EuropeGamma Knife Market, by Anatomy, 2018-2030 (USD Million)
  • TABLE Europe Gamma Knife Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gamma Knife Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gamma Knife Market, by Disease Indications, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gamma Knife Market, by Anatomy, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gamma Knife Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Gamma Knife Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Gamma Knife Market, by Disease Indications, 2018-2030 (USD Million)
  • TABLE Latin America Gamma Knife Market, by Anatomy, 2018-2030 (USD Million)
  • TABLE Latin America Gamma Knife Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gamma Knife Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gamma Knife Market, by Disease Indications, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gamma Knife Market, by Anatomy, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gamma Knife Market, by End User, 2018-2030 (USD Million)
目次
Product Code: ANV1483

REPORT HIGHLIGHT

Gamma knife market size was valued at USD 480.9 Million in 2022, expanding at a CAGR of 5.3% from 2023 to 2030.

The gamma knife market is defined as the global market for gamma knife-related products & services and radiosurgery systems. Additionally, it is a non-invasive surgical technology utilized in the treatment of several neurological conditions, primarily other brain disorders. Moreover, it involves highly focused radiation beams to precisely target and treat certain areas of the brain while reducing damage to healthy surrounding tissues.

Gamma Knife Market- Market Dynamics:

Non-invasiveness & minimal side effects, awareness & acceptance, and technological advancement will boost the market growth

The Gamma Knife procedure does not require open surgery and it is non-invasive. In addition, it uses focused radiation beams to target and treat specific brain areas while sparing surrounding healthy tissues. It reduces side effects and the risk of complications over traditional surgical methods, making it a unique option for patients. Moreover, the benefits of Gamma Knife surgery are attributed to a growing awareness among healthcare and patient professionals. The acceptance and use of this technology are increasing globally as more clinical evidence supports its safety and efficacy. However, the product manufacturing high cost and lack of suitable infrastructure are expected to obstruct market growth. Furthermore, in gamma knife technology continued advancements present opportunities for market growth. In line with this, manufacturers can focus on treatment planning software, improving imaging capabilities, and radiation delivery systems to improve efficiency, precision, and patient outcomes. The applicability of Gamma Knife technology could also be expanded by developing more versatile and compact systems. This, in turn, such factors projected to drive the gamma knife market demand.

Gamma Knife Market- Key Insights:

  • As per the analysis shared by our research analyst, the global gamma knife market is estimated to grow annually at a CAGR of around 5.3% over the forecast period (2023-2030)
  • The gamma knife industry is projected to grow at a significant rate due to the growing awareness among healthcare and patient professionals
  • Based on indications segmentation, cancer was predicted to show maximum market share in the year 2022
  • Based on anatomy segmentation, head was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Gamma Knife Market- Segmentation Analysis:

The global gamma knife market is segmented on the basis of disease indications, anatomy, end user, and region.

The market is divided into eight categories based on disease indications: cancer, ocular diseases, brain metastasis, vascular disorders, functional disorders, movement disorders, trigeminal neuralgia, arteriovenous malformation (AVM), and others. The cancer segment is expected to dominate the market over the forecast period owing to the new cancer cases and cancer death. Additionally, in this case, an essential thing to remember is a particular portion of the market is made up of brain cancer. Moreover, when a patient's cancer is surmounted to stage four, there is a considerable possibility that it has affected the patient's brain. Thus, these elements are attributed to increasing segment growth.

The market is divided into two categories based on anatomy: neck, head, and others. The head segment is likely to maintain its dominance in the market. The effective and the non-invasive treatment of deep tumors in the head using this method, owing to such factors propelling the segment demand. Additionally, neurosurgery poses a great risk to the safety of the patient, thus deep tumors or cancer in the head is majorly done by gamma knife treatment.

The market is divided into three categories based on end-users: ambulatory service centers, hospitals, and clinics. The hospital segment is likely to possess the largest revenue share in the market. In the healthcare sector, the increasing technological advancement is expected to surge segment growth. Moreover, as a computer-guided treatment, the gamma knife process enables surgeons to perform the procedure at the highest level of accuracy. This is attributed to the surge in the market share while also promoting the utilization of imaging software.

Gamma Knife Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Gamma Knife Market- Competitive Landscape:

The gamma knife market is rising steadily owing to the increasing incidence of neurological disorders. Moreover, the global gamma knife market is driven by growing R&D activities, collaboration, and new product launches. One of the main elements fueling the market's rapid rise is strategic initiatives by the key market players including technology, availability, product cost, and performance. Furthermore, to acquire a competitive advantage key players are expanding their product offerings. For instance, Leksell GammaPlan is advanced treatment planning and management software that is fully compatible with Leksell Gamma Knife and is particularly designed to meet intracranial radiosurgery requirements. Additionally, it offers certain tools that make complete use of the advanced technology implemented into the system while ensuring efficient and safe treatment workflows.

Recent Developments:

For instance, in October 2022, Varian and Cincinnati Children's/University announced clinical trial results from FAST-01 (FeAsibility Study of Flash Radiotherapy for the Treatment of Symptomatic Bone Metastases), the first-in-human experience of proton Flash and the first clinical trial of ultra-high dose rate Flash therapy.

Key features of the study:

  • This proposed research study on gamma knife market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the gamma knife market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for gamma knife market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the gamma knife market.
  • Impact of COVID-19 on gamma knife market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on gamma knife market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the gamma knife market, we have also included competitive landscape and key innovator analysis for the gamma knife market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the gamma knife market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global gamma knife market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GAMMA KNIFE MARKET KEY PLAYERS

  • American Shared Hospital Services
  • Hitachi, Ltd.
  • Brainlab
  • GENERAL ELECTRIC COMPANY
  • Elekta AB
  • BondWellOrtho
  • Ono Sokki India Private Limited.
  • Blount Memorial Hospital
  • Panacea Medical Technologies Pvt. Ltd.
  • American Radiosurgery Inc.
  • UT Health East Texas.
  • MASEP
  • UT Health East Texas.

GLOBAL GAMMA KNIFE MARKET, BY DISEASE INDICATIONS

  • Cancer
  • Ocular Diseases
  • Brain Metastasis
  • Vascular Disorders
  • Functional Disorders
  • Movement Disorders
  • Trigeminal Neuralgia
  • Arteriovenous Malformation (AVM)
  • Others

GLOBAL GAMMA KNIFE MARKET, BY ANATOMY

  • Neck
  • Head
  • Others

GLOBAL GAMMA KNIFE MARKET, BY END USER

  • Ambulatory Service Centers
  • Hospitals
  • Clinics

GLOBAL GAMMA KNIFE MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Gamma Knife Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Gamma Knife Market Snippet by Disease Indications
    • 2.1.2. Gamma Knife Market Snippet by Anatomy
    • 2.1.3. Gamma Knife Market Snippet by End User
    • 2.1.4. Gamma Knife Market Snippet by Country
    • 2.1.5. Gamma Knife Market Snippet by Region
  • 2.2. Competitive Insights

3. Gamma Knife Key Market Trends

  • 3.1. Gamma Knife Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Gamma Knife Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Gamma Knife Market Opportunities
  • 3.4. Gamma Knife Market Future Trends

4. Gamma Knife Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Gamma Knife Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Gamma Knife Market Landscape

  • 6.1. Gamma Knife Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Gamma Knife Market - By Disease Indications

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Indications, 2022&2030 (%)
    • 7.1.2. Cancer
    • 7.1.3. Ocular Diseases
    • 7.1.4. Brain Metastasis
    • 7.1.5. Vascular Disorders
    • 7.1.6. Functional Disorders
    • 7.1.7. Movement Disorders
    • 7.1.8. Trigeminal Neuralgia
    • 7.1.9. Arteriovenous Malformation (AVM)
    • 7.1.10. Others

8. Gamma Knife Market - By Anatomy

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Anatomy, 2022&2030 (%)
    • 8.1.2. Neck
    • 8.1.3. Head
    • 8.1.4. Others

9. Gamma Knife Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022&2030 (%)
    • 9.1.2. Ambulatory Service Centers
    • 9.1.3. Hospitals
    • 9.1.4. Clinics

10. Gamma Knife Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Gamma Knife Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Gamma Knife Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Gamma Knife Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Gamma Knife Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Gamma Knife Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Gamma Knife Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. American Shared Hospital Services
    • 11.2.2. Hitachi, Ltd.
    • 11.2.3. Brainlab
    • 11.2.4. GENERAL ELECTRIC COMPANY
    • 11.2.5. Elekta AB
    • 11.2.6. BondWellOrtho
    • 11.2.7. Ono Sokki India Private Limited.
    • 11.2.8. Blount Memorial Hospital
    • 11.2.9. Panacea Medical Technologies Pvt. Ltd.
    • 11.2.10. American Radiosurgery Inc.
    • 11.2.11. UT Health East Texas.
    • 11.2.12. MASEP
    • 11.2.13. UT Health East Texas.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us